The global Pharmacovigilance Market is expected to grow at a CAGR nearly 9.7% during the forecast period (2014 to 2020). This industry was valued at approximately USD 2410 million in 2013. High incidence of adverse drug reaction (ADR) and stringent regulatory norms pertaining to drug safety drive the overall industry. Pharmacovigilance, also known as drug safety involves testing the effects of medical drugs once these have been approved & licensed for use. This is done basically to identify & evaluate adverse reactions that had gone unreported in the past.
It utilizes pharmacological science that helps in the collection, assessment, detection, monitoring, and prevention of drug reactions after pharmaceutical drugs have been consumed. Issues of drug toxicity, rising cases of chronic ailments, and an ever-expanding geriatric population cumulatively impact overall industry demand. Browse Details of Report@ https://www.hexaresearch.com/research-report/pharmacovigilance-industry The worldwide pharmacological market is categorized on the basis of clinical trials, types of methods, service types, and geographies. As per clinical trial phases, the segments are preclinical, phase 0, phases I, II, III, and IV. The usage rate was by far the highest for phase IV in 2013. Before getting the nod from regulatory authorities, phase IV needs to necessarily clear the following vital stages: quality inspection, efficacy test, and safety of use. Data gathered during the post phase III stage is highly reliable & widely accepted. The phase IV trials market holds the largest share, closely followed by the phase III market. As against phase I & II, phase III witnesses maximum drug safety clearances. Based on types of methods, the global Pharmacovigilance Market is categorized into intensified ADR reporting, cohort event monitoring, target reporting, EHR monitoring, and spontaneous reporting. The EHR monitoring segment may expand robustly during the forecast period. This market is fueled by the growing trend of automation & digitalization in healthcare. EHR devices facilitate effective communications between doctors and patients owing to efficient data sharing capabilities electronically. House manufacturing and contract outsourcing are two types of services in the pharmacovigilance market. Contractual outsourcing led the industry in 2013. Due to globalization, developed countries can manufacture goods & services at affordable costs because of outsourcing. Outsourcing leads to lower production failures and helps overcome the problem of depleting stocks. It could even lower fixed costs, facilitate effective resource management, mitigate risks, and reduce upfront investments. Geographically, the global pharmacovigilance industry is divided into Europe, North America, and Asia Pacific. North America dominated the industry in 2013. Implementation of drug safety regulatory norms by FDA and substantial R&D investments are key regional drivers. Asia Pacific could expand robustly during the forecast period because of availability of cheap labor and widespread awareness about ADR. This region offers several lucrative opportunities for further market progress. Prominent competitors in the worldwide pharmacovigilance market are Janssen Research & Development, United BioSource Corporation, Cognizant Technology Solutions Corporation, Boehringer Ingelheim Gmbh, and Bristol-Myers Squibb. Most companies engage in business ventures, such as mergers and acquisitions in order to gain higher market shares. The life sciences industry is a rapidly developing one. Advanced automation is gaining much importance in this industry as it is in the others. While most life sciences companies aim at launching products rapidly & cost effectively, they also need to ensure other key aspects. The devices & drugs being produced, besides fulfilling patient needs, must lead to better outcomes in the short & long term. A number of life sciences organizations have adopted automation for modernization of core enterprise systems. These have proved useful in many ways. In pharmacovigilance, it plays a key role in quality measurement, quantitative studies, customer service, data capture, and cognitive learning for medical report analysis, and others. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit Our Blog - hexaresearch1.blogspot.com
0 Comments
Bioinformatics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2020 | Hexa Research3/22/2017 The global Bioinformatics Market is projected to expand at a CAGR over 21% during the forecast period (2014 to 2020). In revenue terms, the industry could reach nearly USD 14 billion by 2020. It is propelled by growing demand for advanced drugs and prevalence of chronic diseases. Application of information technology for the effective management of biological information is known as bioinformatics.
Affordable costs of DNA sequencing and strong support from private sector organizations & governments are factors that positively impact the global industry. Furthermore, steady developments in IT support for bioinformatics systems may fuel market demand in the forthcoming years. A number of research institutes focus greatly on discovering & developing novel drugs in the area of life sciences. Widespread adoption of bioinformatics in clinical diagnostics is a vital industry driver. Browse details of Report @ https://www.hexaresearch.com/research-report/bioinformatics-industry The global bioinformatics market is segmented on the basis of sectors, products & services, applications, and regions. Based on sectors, the industry is divided into environment biotechnology, animal biotechnology, forensic biotechnology, agriculture biotechnology, academics, forensic biotechnology, and medical biotechnology. The forensic biotechnology segment is a rapidly growing one because of high demand for DNA evidence in legal systems. The sub-segments of medical biotechnology are reproductive biotechnology, clinical diagnostics, drug development, gene therapy, and molecular medicines. Owing to high sunk costs, medical biotechnology holds the highest share in the overall market in terms of revenue. According to products & services, the worldwide industry is categorized into bioinformatics services, bioinformatics platform, and bioinformatics knowledge management tools. Bioinformatics tools are further segmented into generalized knowledge management tools and specialized knowledge management tools. Bioinformatics platforms include sequence alignment platforms, sequence analysis platforms, functional & structural analysis platforms, and sequence manipulation platforms. Bioinformatics services are classified into database management, sequencing service, data analysis, and others. Data analysis and database management are by far the most expensive because of these need human intervention for interpretation and technology for data organization. On the basis of applications, the global Bioinformatics Market is divided into molecular phylogenetics, proteomics, metabolomics, chemo informatics & drug design, transcriptomics, and others. Genomics is anticipated to be the largest market by 2020. And metabolomics may register the highest growth rate during the forecast period. The regional segments of the global Bioinformatics Market are Asia Pacific, North America, Europe, and Rest of the World. North America dominated the overall industry in 2014 owing to technological developments and continuous efforts towards drug discovery & development. The region may retain its leading position throughout the forecast period. Asia Pacific may expand at a remarkable rate because of medical tourism, high investments in healthcare IT, and greater CRO activities. Brazil, China, and India could create significant growth prospects in the forthcoming years. Prominent companies operating in the global industry are Life Technology Corporation, Biomax Informatics AG, CLC Bio, Id Business Solutions, and Nonlinear Dynamics Ltd. In order to understand & block the progression of cancer, researchers have identified certain proteins that get altered in different types of cancers. When these are targeted with drugs that block their activities, the progression of cancer can be halted to an extent. Researchers & scientists from the University of Cambridge and from Hungary utilized databases of genes that are involved in cancer. It was observed that cancer related proteins are strongly connected to the main protein networks. Some of the key proteins in the networks have the capacity to facilitate changes that convert healthy cells into cancer cells. The cancer proteins do not interact directly with another but through their surrounding first neighbors. The concerned researchers have successfully utilized computational methods to identify the exact proteins that need to be targeted by drugs. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-it-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit Our Blog: hexaresearch1.blogspot.com Rising cases of cancer and high incidence of a number of metabolic diseases propel the global Peptide Therapeutics Market. Other industry drivers are prevalence of lifestyle diseases, introduction of hybrid methods of peptides synthesis, growing global population, and improved healthcare infrastructure. A molecule containing two or more amino acids is known as a peptide. Therapeutic peptides are short amino acid monomer chains.
Peptides are commonly known as amide bonds. These are used to treat blood-based disorders, certain types of cancers, chronic ailments, CNS (central nervous system) disorders, and cardiovascular & respiratory anomalies. Growing importance of peptide therapeutics in the pharmaceutical market may significantly contribute to overall demand during the forecast period (2012 to 2020). However, changing customer needs and lack of regulatory standards hinder industry progress. Browse Details of Report @ https://www.hexaresearch.com/research-report/peptide-therapeutics-industry The worldwide peptide therapeutics market is categorized on the basis of technologies, applications, routes of administration, products, and regions. Based on technologies, the segments are HPPS (hybrid phase peptide synthesis), LPPS (liquid phase peptide synthesis), and SPPS (solid phase peptide synthesis). Owing to cost effectiveness and user-friendliness, SPPS was the largest contributor to the overall industry in 2013.On the basis of applications, the market is divided into respiratory, cancer, anti-infection, pain, metabolic, cardiovascular, dermatology, renal, gastro intestinal, and others. In 2013, peptide therapeutics were used extensively in cancer treatment. High incidence of cancer cases worldwide is expected to fuel this segment till 2020. According to routes of administration, the industry is segmented into mucosal, pulmonary, parenteral, oral, and others. “Others” includes nasal and intradermal. Parenteral held the highest industry share in 2013. Based on products, the bifurcations are generic and innovative. Innovative peptides dominated the overall industry in 2013. As per regions, the global peptide therapeutics market is categorized into Europe, Asia Pacific, North America, and Rest of the World. North America leads the global industry because of high per capita expenditure on healthcare, rising income levels, and improvements in healthcare infrastructure. The region receives substantial support from the government and also from a number of NGOs. Asia Pacific may witness robust growth over the forecast period because of economic progress, favorable government initiatives, and growing population. Japan, China, and India are the three key regional drivers of the Asia Pacific market. Prominent companies operating in the global peptide therapeutics market are Eli Lilly and Company; Takeda Pharmaceutical Company Ltd.; Amylin Pharmaceuticals LLC; Bachem Holding AG; and Teva Pharmaceuticals. Rhythm, a U.S. based biopharmaceutical company dealing in peptide therapeutics presented the phase 2 clinical trial assessment of setmelanotide in November 2016. Setmelanotide, a peptide drug, is the company’s melanocortin-4 receptor agonist that is generally used to treat LepR (leptin receptor) deficiency obesity. This is a rare genetic anomaly that leads to unrelenting hyperphagia and severe obesity. According to the company, this disorder affects nearly two thousand people in the U.S. on an annual basis. Caused by deficiencies & defects in the MC4 pathway, LepR deficiency obesity affects people in their early childhood. The MC4 pathway in humans regulates appetite, energy expenditure, and homeostasis. Setmelanotide’s efficacy was tested by researchers when it was administered everyday by subcutaneous injection. Over a period of 22 weeks, a LepR patient lost weight by almost 20%. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/clinical-diagnostics-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit Our Blog: hexaresearch1.blogspot.com The Craniomaxillofacial (CMF) Devices Market is estimated to grow at a CAGR over 6.7% during the forecast period (2016-2024). Demand for minimal invasive procedures which can heal rapidly is the primary driving factor of the market. Awareness of these surgeries by ASCFS and ISCFS will facilitate in market growth. Bigger healthcare budget, use of 3D implants in reconstructive surgery, and growing geriatric populace are other aspects favoring the market.
The global market is segmented according to products, materials, applications, and regions. Products include cranial flap fixation, MF (maxillofacial) plate and screw-fixation, bone graft substitutes, and CMF distraction. Plate and screw fixation earned over 70% market revenue shares in 2014 due to their varied use in surgeries. Materials used are metal, bioabsorable, and alloys. Titanium alloys are used to produce cranial plates due to their low weight & non-corrosive property. Polymers such as PMMA (poly methyl methacrylate) and Medpor are used due to their biocompatible nature. Biomaterials such as PDLLA and PPEK are used in bioabsorbable devices. Neurosurgery & ENT, orthognathic & dental, plastic surgery, and others constitute as market applications. Increasing cases of spinal disorders will bring in revenues from the neurosurgery & ENT segment. Plastic surgery will see growth in the years ahead from developed countries of Canada and U.S. Browse Details of Report @ https://www.hexaresearch.com/research-report/craniomaxillofacial-market Regions covered under the market are Latin America, North America, Europe, Asia Pacific, and Middle East & Africa. North America accounted for over 58% market revenue in 2014. Other factors supporting market growth in the region are technological developments, healthcare infrastructure, and high patient awareness. Europe is in need of technology which can cater to plate and screw fixation, thoracic fixation, CMF bone graft substitutes, and temperomandibular joint (TMJ) replacement. This is expected to net revenues over USD 227 million in 2013. Asia Pacific will exhibit growth due to economic development and improving healthcare infrastructure. Well-known players of the craniomaxillofacial devices market are Aesculap; Johnson & Johnson (DePuy Synthes); Boston Medical Products Inc.; and Medartis AG. Research and development of products are one of the strategies followed by players. For instance, Aesculap introduced Pro space, a osteoconductive interbody fusion method in 2015. Browse Related Category Market Reports@ https://www.hexaresearch.com/research-category/medical-devices-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit our Blog: hexaresearch1.blogspot.com The Pharmacy Automation Devices Market is anticipated to expand at a CAGR nearly 7.4% during the forecast period (2014 to 2020). Revenues may surpass USD 8 billion by 2020. Mechanical processes that are used in the handling and distribution of medications are known as pharmacy automation. Pharmacies employ automation in order to enhance cash flows and bring down medication inventories. Devices that facilitate these tasks are known as pharmacy automation devices. High incidence of medical error deaths is one of the key drivers of this industry.
Computerized physician order entry, EHR (electronic health record), and clinical decision support system are some of the commonly used devices. These help monitor patients on a regular basis so that their health conditions are better understood. High investments in research & development and growing popularity of medical automation may augment industry growth over the forecast period. Other market drivers are need for minimal medical errors, greater consciousness about advanced pharmacy, and high population growth. Furthermore, demand for minimally invasive surgical procedures with integrated medical automation could propel the industry in the forthcoming years. Browse Details of Report@ https://www.hexaresearch.com/research-report/pharmacy-automation-device-industry Applications, end-use, and regions are the three parameters based on which the global pharmacy automation devices market is categorized. Based on applications, the segments are automated medication dispensing systems, automated medication & compounding systems, automated storage & retrieval systems, table top tablet counters, and automated packaging & labeling systems. Packaging & labeling instruments mainly include deblistering machines, sealers, printing solutions, and fillers & sealers. Automated medication dispensing systems enable computer controlled storage, tracking, dispensation, and the efficient recording of medical works. This segment held the highest market share in 2013. Unlike small sized hospitals that face budgetary constraints, highly established & large hospitals mainly adopt automated medication dispensing systems. Dispensing cabinets help healthcare practitioners to provide medications in a systematic manner and keep a record of the same in the overall system. Retail pharmacy and hospital pharmacy are the two main end-users in the overall industry. Owing to robust investments, the hospital pharmacy segment may witness remarkable growth till 2020. It is sub-segmented into central pharmacy automation solutions, pharmacy robots, barcode medication dispensing, and point-of-care automation solutions among others. Geographically, the worldwide pharmacy automation devices industry is divided into Asia Pacific, North America, Europe, and Rest of the World. In revenue terms, North America dominated the overall industry in 2013. Regional drivers are technological developments, the need for minimal medical errors, and a rapidly growing aging population. Asia Pacific is projected to be the fastest growing region in the forecast period. Factors that could positively impact the region are high income levels and greater awareness about the benefits of medical automation. Prominent players in the global Pharmacy Automation Devices Market are Innovation PharmaAssist Robotics, Pyxis Pharmacy Automation Systems, McKesson Corporation, CareFusion Corporation, Accu Chart Healthcare, and Swisslog Holding Ltd. TCGRx, a Wisconsin based company dealing in pharmacy automation declared the development of PillBot™ in November 2016. PillBot™ is a pharmacy automation device that enables the filling of multi-dose and unit-dose cards in addition to pouch packaging. It can efficiently package medicines in blister formats as well as in pouch formats. The product will soon be launched this year. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit Our Blog - hexaresearch1.blogspot.com The Global Microscopes Market is projected to reach nearly USD 7.4 billion by 2020. Key factors that drive the industry are technological innovations and surging private sector & government sector investments. Nanotechnology being a continuously evolving field has a favorable impact on overall market demand. Intensive R&D in life sciences & semiconductors is expected to fuel industry growth over the forecast period (2012 to 2020). Popularity of super resolution microscopes can be attributed to continuous technological innovations. Such microscopes are highly effective & convenient especially when it comes to examining complex human body parts, such as the neurological system & the brain.
Introduction of high resolution & cost effective microscopes, such as the dSTORM (direct stochastic optical reconstruction optical microscopy) may catapult demand till 2020. The microscopes market in most developing economies is driven by availability of cheap labor and favorable government policies. Interestingly, these factors fuel demand for semi-conductors and induce greater research in life sciences & nanotechnology. Browse Details of Report @ https://www.hexaresearch.com/research-report/microscopes-industry The worldwide microscopes market is categorized on the basis of products, applications, and geographies. As per products, the segments are optical, scanning probe, electron and others. Fueled by high adoption rates in life sciences & semiconductors and widespread applications, optical microscopes generated highest revenues in the overall market in 2013. These microscopes are further categorized into near field scanning, confocal scanning, fluorescence, phase contrast, stereomicroscope, inverted, and others. Inverted microscopes held the largest market share in 2013. Applications in metallurgy & micromanipulation could fuel demand for inverted microscopes. This segment is expected to grow robustly over the forecast period. Based on applications, the global industry is divided into semiconductors, life sciences, nanotechnology, material sciences, and others. The market was led by the life sciences segment in 2013. Demand is mainly fueled by innovations in consumer electronics, and use of microscopes in manufacturing & inspection and in research & development. Newer areas of application, such as miniature transistor chips and quantum dots could drive the overall industry in the forthcoming years. Quantum dots is a gradually evolving technology that may cater to several application areas, like quantum computing, electroluminescent displays, diode lasers, biological imaging, photovoltaic cells, and transistors in the years to come. Regional segments of the global microscopes market are Europe, Asia Pacific, North America, and Rest of the World. Asia Pacific dominated the overall industry in terms of revenue in 2013. In 2011, China witnessed the highest rate of funding in its nanotechnology industry globally. Industrialization coupled with use of nanotechnology in research & development may create lucrative opportunities for further growth of the global market. Furthermore, demand for microscopes from noncommercial organizations (hospitals and research laboratories) can also play a significant role in triggering market progress. Companies operating in the global industry are Carl Zeiss, Olympus Corporation, Leica Microsystems, and Nikon Corporation. Since there are only a few participants, this market is characterized by minimal competition. It is essentially oligopolistic in nature. Scientists from Uppsala University, Stockholm University, and University of California have created a 3D printed cell phone attachment that can turn a particular device’s camera into a microscope. Such an innovation aims at helping health workers in developing nations and in remote locations to identify genetic mutations that cause illnesses & diseases. With the help of such a device, healthcare professionals do not need to send samples to laboratories. Browse Related Category Market Reports@ https://www.hexaresearch.com/research-category/medical-devices-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit Our Blog - hexaresearch1.blogspot.com The global Ablation Technology Market is primarily driven by high incidence of chronic illnesses, such as cancer. Rising cancer cases fuel the need for minimally invasive procedures for diagnostics purposes. Surgical removal of body tissues is carried out by minimally invasive procedures. These procedures employ ablation technologies. Besides being economical, ablation technologies ensure quick recovery and cause lesser damage to body tissues. They also ensure lower risks of infection.
Favorable government initiatives and a rapidly growing geriatric population are factors that positively impact demand. Owing to high success rates in diagnosis of chronic illnesses and minimal risks, developing economies, such as Brazil, India, Russia, and China are gradually adopting ablation technologies. It is anticipated that popularity of minimally invasive procedures and surging per capita expenditure on healthcare may propel the ablation technology market during the forecast period (2012 to 2020). Browse Details of Report @ https://www.hexaresearch.com/research-report/ablation-technology-industry The worldwide industry is segmented on the basis of technologies, applications, and regions. Based on technologies, the Ablation Technology Market is divided into radiofrequency, ultrasound, electrical, and radiation. Due to widespread scope in cancer diagnosis, radiation technology led the global market in 2013. Other factors that may positively impact this segment in the forthcoming years are availability of different types of radiation devices and high incidence of cancer. The segment for electrical ablation may expand robustly over the forecast period. This attributes to rising prevalence of cardiovascular disorders, such as atrial fibrillation. Ablation technologies are predominantly applied in orthopedics, ophthalmology, cardiovascular procedures, and in cancer. Use of ablation technologies in cancer diagnosis generated the highest revenues in 2013. Growing awareness about the popularity of ablation technology in cancer treatment is projected to fuel overall market demand. Cardiovascular applications are expected to increase considerably over the forecast period. Geographically, the global ablation technology market is fragmented into Europe, Asia Pacific, North America, and Rest of the World. North America held highest shares in the overall industry back in 2013. Awareness about ablation technologies and large number of people suffering from chronic diseases are key regional drivers. Ongoing industry trends suggest that Asia Pacific may expand remarkably in the years to come. The region is essentially propelled by surging healthcare expenditure and application of ablation technologies in diagnostics solutions. Growing preference for ablation over surgeries and substantial government spending on ablation technology could further contribute to regional demand. Key companies operating the worldwide market are Boston Scientific Corporation, Olympus Corporation, AngioDynamics Inc., Medtronic Inc., and AtriCulture Inc. among others. Most industry participants focus greatly on innovations that aim at enhancing accuracy & efficiency of test results. Researchers have developed a cryoablation system that can attain much cooler temperatures than most conventional cryoablation technologies. The new system can effectively create transmural ventricular lesions from the epicardium as well as the endocardium. It may prove beneficial for catheter-based & surgical ventricular tachycardia ablations in humans. This cryoablation technology utilizes liquid nitrogen and achieves temperatures as low as minus 160 degrees Celsius. This IceSense cryoablation system helps debulk tumors in lungs, kidneys, liver, and breast. It comprises a freezing element and a rigid probe that has a sharp needle tip. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit our Blog: hexaresearch1.blogspot.com |
Archives
October 2023
|